Treatment of breast cancer with different antiprogestins: Preclinical and clinical studies
- 20 December 1990
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 37 (6) , 789-794
- https://doi.org/10.1016/0960-0760(90)90421-g
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer modelsThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- The antiprogestins: A recent advance in fertility regulationJournal of Steroid Biochemistry, 1987
- Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cellsBreast Cancer Research and Treatment, 1987
- Effects of the Progesterone Antagonist RU486 on Ovarian Activity in the Rat*Endocrinology, 1987
- ANTIFERTILITY ACTIONS OF THE PROGESTERONE ANTAGONIST RU 486 INCLUDE DIRECT INHIBITION OF PLACENTAL HORMONE SECRETIONThe Lancet, 1987
- Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)New England Journal of Medicine, 1986
- Fertility control in women: Results with RU 486 by the end of 1985Journal of Steroid Biochemistry, 1986
- Effects of the Antiprogesterone Steroid RU 486 during Midluteal Phase in Normal WomenJournal of Clinical Endocrinology & Metabolism, 1985
- RU 38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activationJournal of Steroid Biochemistry, 1984
- 319 Progestins, antiprogestins and progesterone receptors in breast cancer: Mechanisms and biological actionsJournal of Steroid Biochemistry, 1983